NCT03429257View on ClinicalTrials.gov

Maternal EED and Aflatoxin Birth Outcomes Study Uganda

CompletedOBSERVATIONAL
Enrollment

258

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2017

Conditions
Birth WeightPregnancy PretermAflatoxins ToxicityInflammatory Response
Interventions
OTHER

Exposures of interest: Maternal EED and Aflatoxin Exposure

Maternal EED, measured via lactulose: mannitol (L:M) ratios and serum concentrations of antibodies to the bacterial components flagellin and lipopolysaccharide (LPS); Maternal aflatoxin exposure, measured via serum concentration of AFB1-lysine adduct

Trial Locations (1)

Unknown

Mukono Health Center IV, Mukono

All Listed Sponsors
collaborator

United States Agency for International Development (USAID)

FED

collaborator

Harvard School of Public Health (HSPH)

OTHER

lead

Tufts University

OTHER

NCT03429257 - Maternal EED and Aflatoxin Birth Outcomes Study Uganda | Biotech Hunter | Biotech Hunter